VIT 3.95% 7.3¢ vitura health limited

obvious capping, page-6

  1. 709 Posts.
    While the issue is fully underwritten the need for the funds indicates that Colletech is not likely to have sales revenue anytime soon. It is a major concern that they still have not sold any significant quantity of cosmetic grade collagen, which is suppose to be a large market. Can't wait till their next quarterly to see how fast they are continuing to burn cash.
 
watchlist Created with Sketch. Add VIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.